Dosidal · Poland
pl:authorisation:100427770
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Poland |
|---|---|
| Record | pl:authorisation:100427770 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | pl-authorisation: rpl-product-id: 100427770 |
| Source authority | URPL |
| Read date | |
| authorisation status | state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| identity | atc: L04AF03 common_name: Upadacitinibum form: Tabletki o przedłużonym uwalnianiu holder: AbbVie Deutschland GmbH & Co. KG medicine: Rinvoq procedure: CEN routes: doustna strength: 15 mg substances: amount: 15 substance: Upadacitinibum unit: mg state: current · read 2026-11-15T02:02:49Z · source: URPL / Rejestr Produktów Leczniczych (Centrum e-Zdrowia export) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d53mCOI2rnlftftw6XePm2lVfBu1KY8R-SgfNUAoZfH84TqGGfnL_hynlvRskk_JJ8Sn321llacPn7h128Bmvhp5wVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/pl:authorisation:100427770 · Same medicine in other markets · Dosidal